Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCON: Prostate radiotherapy with carbogen and nicotinamide
2010-021886-63Phase 2Completed
- Sponsor
- East and North Hertfordshire NHS Trust
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of nicotinamide and carbogen in prostate cancer (PCa), sponsored by East and North Hertfordshire NHS Trust. Primary endpoint: Biochemical relapse. Started Jun 2011; status: completed.
02
Drugs
nicotinamidecarbogen
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2010-021886-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021886-63.